Multimodal longitudinal clinically annotated data set
Search documents
Tempus AI, Inc. (TEM) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Seeking Alpha· 2026-03-03 20:12
Core Perspective - Tempus is positioned as a unique player in the healthcare sector, integrating genomics with a large multimodal longitudinal clinically annotated data set, enhanced by AI technology [1] Company Overview - Tempus is recognized primarily as a genomics company, which still constitutes a significant portion of its revenue [1] - The company has evolved to incorporate AI into its operations, suggesting a broader focus beyond just diagnostics [1] Industry Context - The integration of AI into healthcare data management is becoming increasingly important, with companies like Tempus leading the way in this transformation [1] - The discussion highlights the potential for AI to enhance the utility of existing healthcare data, particularly in oncology [1]